Results revealed that, compared to WT controls, liver-specific SIRT5-overexpressing mice exhibited markedly reduced MI area and degree of myocardial fibrosis, accompanied by significantly elevated levels of secreted fibroblast growth factor 21 (FGF21) in the circulation. This evidence concerns the gene SIRT5 and myocardial infarction.